Hospital Admin Articles

Hospital Admin

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

the specialty pharmaceuticals company, provides the following update for the year ended March 2009 ahead of the planned publication of its Preliminary Results on May 2009. Recurring royalty revenues from licensed products and annualised sales revenues from CroFab and DigiFab are anticipated to be higher than in the previous year. Operating expenses and research and development expenses are anticipated to be in line with expectations. The Group anticipates that the majority of the estimated £10m of restructuring provisions associated with the acquisition of Protherics PLC will be taken in the year ended March 2009.

Today in Licensure/Accreditation...keeping you current

New ncqa disease management standards focus on measurement, quality improvement and transparency
National Committee for Quality Assurance (NCQA), 12/15/09

EDI Accrediting Firm Updates Criteria
HealthDataManagement, 12/09/09

Consumer Demand for H1N1 Information Highlights Importance of Accreditation for Health Call Centers
URAC News Releases, 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address